The complete guide to Right to Choose for ADHD and autism assessment in the UK

Right to Choose is presented to patients as a route around the NHS waiting list and treatment crisis for ADHD and autism (thus AuDHD) assessment and care — Right to Choose being a statutory right under the NHS Constitution that lets you choose an independent provider, with the NHS paying for the assessment. On paper, this is the system extending itself through market mechanisms to deliver care where its direct capacity has fallen short. In practice, it is a more complicated thing than the framing suggests, and the navigation requires understanding both what the pathway actually delivers and what it does not.

This guide covers what Right to Choose is, who it is for, how to use it, what to do when GPs refuse to refer you (which they often will), what to do when the shared care arrangement fails (which it often does), and what to do when the provider’s NHS contract ends and you find yourself discharged from care you thought was settled. It covers the full pathway and the documented failure modes, written for the patient who needs to navigate the system in 2026 with realistic expectations of what they are stepping into.

Frequently asked questions about Right to Choose

What is Right to Choose for ADHD and autism assessment?

Right to Choose is a statutory right under the NHS Constitution that allows patients in England to choose any approved NHS provider for their first outpatient appointment, including for ADHD and autism assessment. This means a patient whose local NHS service has a multi-year waiting list can elect to be referred to an approved independent provider with a shorter wait, and the assessment is funded by the NHS at no cost to the patient. The pathway requires a GP referral. The assessment, the diagnostic report, and (where indicated) the initial medication titration are all funded by the NHS rather than paid for privately.

Is Right to Choose available everywhere in the UK?

No. Right to Choose applies in England only. Scotland, Wales, and Northern Ireland have different healthcare arrangements and the statutory right does not extend to them. Within England, Right to Choose is a national entitlement and applies across all 42 integrated care boards, though the practical implementation varies significantly between regions and individual GP practices: see the Directory’s FoI dataset for which ICBs are actively refusing the Right to Choose pathway.

How long does Right to Choose take?

Right to Choose waiting times depend on the chosen provider rather than on the local NHS service, which is the point of the pathway. Most approved providers report waiting times of a few months to around a year, compared with NHS direct waits of two to eight years. The exact time varies by provider and by the patient’s specific circumstances. Some providers publish current waiting times on their websites; the Neurodiversity Directory’s verified listings cover the established approved providers with current information on their pathways.

Does Right to Choose cost anything?

No. The assessment, the diagnostic report, and the initial medication titration are all funded by the NHS. The patient pays nothing for the Right to Choose pathway itself. Some patients later incur costs if the GP practice refuses to enter shared care for ongoing prescribing, in which case private prescribing through the original provider becomes the only available route to continued medication — but this is a downstream failure of the system, not a cost of Right to Choose itself.

Can my GP refuse to make a Right to Choose referral?

Legally, no. Right to Choose is a statutory patient right, not a discretionary GP decision. In practice, many GPs refuse Right to Choose referrals or claim not to understand the process. This is one of the most common obstacles patients encounter. When a GP refuses, the options are to ask for the refusal in writing (many GPs will withdraw a verbal refusal when asked to document it), escalate to the practice manager, change GP practices, or submit a formal complaint to the integrated care board. The refusal is not lawful, but the legal position does not automatically translate into easy access without active patient advocacy.

What is shared care for ADHD and autism?

Shared care is the arrangement under which a specialist provider (the assessor) and a GP practice agree to share responsibility for the patient’s ongoing care after diagnosis. The specialist provides the diagnostic assessment, initial titration, and clinical oversight. The GP provides ongoing prescriptions and primary care follow-up. Shared care is the mechanism by which a diagnosed patient transitions from specialist-led to GP-led ongoing care. Some GP practices refuse shared care arrangements with Right to Choose providers specifically, which leaves patients with a confirmed diagnosis but no NHS-funded route to ongoing medication.

What happens if my GP refuses shared care after Right to Choose diagnosis?

If the GP practice refuses shared care, the patient has several options. They can continue with the original provider on a private basis, paying directly for ongoing prescribing. They can change GP practices to one that will accept shared care arrangements with their provider. They can submit a formal complaint to the integrated care board on the basis that the refusal undermines the Right to Choose pathway. None of these options is straightforward, and the shared care gap is one of the most consistent points of failure in the Right to Choose system.

What happens if my Right to Choose provider's NHS contract ends?

When an NHS-contracted Right to Choose provider’s contract is terminated by the integrated care board, the provider can no longer accept NHS-funded patients. The patient relationship does not transfer to NHS specialist care, because the NHS does not directly provide specialist ADHD or autism services in most areas. The patient is typically discharged by the provider and required to re-enter the Right to Choose pathway with a different provider. This often involves being asked to complete first-time assessment forms despite already having a documented diagnosis. The pattern is documented in editorial coverage of lived-experiences on this site.

Is Right to Choose available for children?

Right to Choose for children operates differently from the adult pathway, with different provider networks, different waiting times, and different shared care arrangements. The general principle — that patients can choose an approved independent provider with NHS funding — applies, but the practical pathway varies more substantially for children. Parents pursuing Right to Choose for a child should research providers that specifically work with paediatric assessment and confirm the local pathway with their GP and the integrated care board.

Should I use Right to Choose or pay privately?

For most adults seeking ADHD or autism diagnosis in 2026, Right to Choose is the route that combines the lowest financial cost with the shortest realistic timeline. The NHS direct pathway, asides from being materially non-existent, is free but takes years. The private pathway is fast but costs £600 to £2,500 for the assessment alone, with ongoing prescribing costs on top. Right to Choose is free and faster than the NHS direct pathway, with the caveat that the navigation requires active engagement and willingness to push back against gatekeeping. The right pathway depends on the individual’s circumstances, but for patients who can navigate institutional friction, Right to Choose is generally the strongest option.

What Right to Choose actually is — and what it is not

Right to Choose is a statutory right granted to patients in England under the NHS Constitution. The right covers first outpatient appointments at any approved NHS provider, which means a patient referred by their GP can elect to be seen by a private clinic that holds an NHS contract rather than waiting for their local NHS service. The provider is paid by the NHS on a per-assessment basis. The patient is seen within weeks or months rather than years. The pathway results in a diagnostic letter that is recognised by the NHS and held in the patient’s NHS record alongside any other clinical documentation.

This is how the pathway is presented to patients, and within those mechanics it is accurate. The NHS Constitution does grant the right. Approved providers do hold NHS contracts. Assessments are funded. Waiting times are shorter. For many patients, Right to Choose is the difference between being diagnosed within the current year and being on a waiting list whose endpoint cannot be reasonably predicted.

What the framing obscures is the underlying architecture. The NHS specialist services that Right to Choose is presented as bypassing have not been bypassed; in most areas, they no longer materially exist. Right to Choose is not patient choice between NHS specialist care and private specialist care delivered at NHS cost. It is, for ADHD and autism assessment in particular, the only specialist care available, just structured as if it were a choice. The NHS no longer invests meaningfully in primary-care capability to manage neurodivergent conditions. The work is offloaded to private providers operating under NHS contracts, paid per invoice, returning diagnostic documentation that goes back into the NHS record without the NHS having developed the capability to produce that documentation directly.

This matters for the patient using the system because it shapes what to expect. The Right to Choose provider is not an alternative to NHS specialist care; it is the specialist care the NHS have structurally abdicated providing themselves. The relationship is invoice-mediated. When the contract ends — and contracts have been ending at scale across multiple integrated care boards over the past two years — the patient is not transferred back to NHS specialist care, because there is no NHS specialist care to be transferred to. The patient is discharged and required to re-enter the Right to Choose pathway with a different provider. The “right to choose” turns out, in this light, to be the right to be processed by whichever invoice-paying provider currently holds the contract, with the choice between contracts decided by the integrated care board rather than by the patient.

The Directory’s editorial coverage of this pattern, drawn from first-person experience of the discharge mechanism and supported by Freedom of Information data across all 42 English integrated care boards, makes the case that Right to Choose functions as an alibi structure for NHS abdication of responsibility for neurodivergent primary care, dressed up in the language of progressive choice and empowerment. The dedicated piece (already linked) on the “Right to Choose con” sets out the architectural reading in full.

None of this means patients should not use Right to Choose. For most adults seeking ADHD or autism diagnosis in England in 2026, it is the strongest available pathway. The point of naming the architecture is not to discourage use but to set expectations correctly. The patient who uses Right to Choose with realistic understanding of what the pathway is — and what it is not — is in a stronger position than the patient who uses it expecting that diagnosis will resolve into stable NHS-funded specialist care. The second patient is set up to be blindsided when the architecture shifts beneath them.

Who Right to Choose is for, and who it is not for

Right to Choose for ADHD and autism assessment is available to patients in England who are registered with an NHS GP and who can secure a GP referral. The pathway is open to adults and children, though the provider networks differ and the practical accessibility varies by region.

The pathway is most useful for patients whose local NHS direct waiting list is unreasonably long — which, in 2026, includes most adults in most regions of England. NHS direct waits for adult ADHD assessment range from eighteen months to over eight years depending on the integrated care board. Adult autism assessment waits follow a similar pattern. For patients facing these waits, Right to Choose is the most realistic route to assessment within a useful timeframe.

The pathway is less useful for patients whose local NHS direct service has a manageable waiting list, which is a small minority of regions. In these areas, going through the NHS direct pathway may be cleaner because it avoids the shared care transition problem that Right to Choose introduces. Patients in this position should compare their local NHS direct wait with the wait at their preferred Right to Choose provider and weigh the trade-offs.

The pathway is not available to patients outside England. Scotland, Wales, and Northern Ireland have different healthcare arrangements and the statutory right does not extend to them. Patients in these nations have different pathways available but should not rely on guidance written for the English system.

The pathway requires GP cooperation. In practice, this is one of the most significant variables affecting whether Right to Choose is accessible to a given patient. Some GPs make Right to Choose referrals readily and understand the process. Others refuse referrals, claim ignorance, or actively discourage patients from pursuing the pathway. The patient’s GP practice is one of the strongest determinants of whether Right to Choose works for them, and patients should not assume the pathway is straightforward simply because they are entitled to it.

The pathway requires some capacity for self-advocacy. The patient needs to research approved providers, identify the one that matches their needs, make the request to the GP, navigate any GP resistance, follow up on the referral, attend the assessment, and handle the shared care transition afterwards. None of this is unreasonable, but it is more administrative work than the average GP-led NHS pathway would require, and patients whose ADHD or autism makes administrative tasks particularly difficult may find the pathway harder to navigate than the framing suggests. Support from family, friends, or advocates can substantially ease the navigation. Several Right to Choose providers also offer pre-referral support that helps with the GP conversation specifically.

How to use Right to Choose — the pathway in practice

The pathway in its standard form follows four steps: identifying an approved provider, requesting the GP referral, attending the assessment, and transitioning to shared care for ongoing prescribing if medication is indicated.

The first step is identifying an approved provider. An approved Right to Choose provider for ADHD or autism assessment must hold an NHS contract for the relevant service. Several established providers operate across England, with varying specialisms, waiting times, and approaches to assessment. The Neurodiversity Directory’s verified listings cover the established providers, with manual verification of credentials, no paid placements, and current information on their pathways. When evaluating providers, the relevant factors are the assessor’s qualifications, the structure of the assessment, the current waiting time, the geographic coverage of the provider, and the provider’s approach to post-diagnostic care and shared care transition. Cost is not a factor at this stage because Right to Choose is NHS-funded; the question is which provider is the best clinical fit for the patient’s needs.

The second step is requesting the GP referral. The patient books a GP appointment, explains that they want to be referred for ADHD or autism assessment via Right to Choose, and provides the GP with the chosen provider’s details. The GP writes the referral letter and sends it to the provider. The patient receives confirmation from the provider that the referral has been received and is on the waiting list.

This is the step at which most pathway failures occur. GPs often refuse, delay, or obstruct Right to Choose referrals. The specific patterns of GP resistance and the practical responses to them are covered in the next section.

The third step is the assessment itself. Approved Right to Choose providers conduct assessments following NICE guidelines. For adult ADHD assessment, this typically involves a structured clinical interview lasting 90 minutes to three hours, completion of validated questionnaires such as the DIVA-5 and ASRS, consideration of childhood symptoms and developmental history, and differential diagnosis to rule out other explanations for the symptoms. For autism assessment, the process is similar but uses different instruments and typically requires more time and more developmental history. The assessment is conducted by a psychiatrist, specialist nurse, or specialist psychologist depending on the provider. The patient receives a written diagnostic report within a few weeks of the assessment, documenting the diagnostic conclusion and any recommendations for treatment.

The fourth step is the shared care transition, where relevant. For patients diagnosed with ADHD where medication is indicated, the provider conducts initial medication titration over several months to find the optimal type and dose. Once titration is complete, the provider arranges to transfer ongoing prescribing to the patient’s GP practice through a shared care agreement. The provider supplies the GP with a shared care protocol and any clinical documentation needed. The GP agrees to take over prescribing under the protocol. The patient’s ongoing prescriptions are then issued by the GP practice rather than the original Right to Choose provider.

This is the step at which the second major pathway failure occurs. Some GP practices refuse to enter shared care arrangements with Right to Choose providers, leaving the patient with a confirmed diagnosis and titrated medication but no NHS-funded route to continued prescribing. The shared care problem and the practical responses to it are covered in section five.

When the pathway works, the patient moves through these four steps in a roughly twelve-to-eighteen-month timeframe, ending with stable NHS-funded ongoing care. When the pathway fails at any of these steps, the patient is forced to navigate additional friction that the standard framing of Right to Choose does not anticipate.

When your GP refuses Right to Choose — and what to do about it

GP refusal is the most common single obstacle to Right to Choose, and the pattern is consistent across regions. The refusal usually takes one of four forms.

The first is outright refusal — the GP says they will not make Right to Choose referrals and directs the patient to the standard NHS direct pathway. This is the most clearly unlawful form of refusal, because Right to Choose is a statutory patient right and the GP does not have discretion to deny it. But it happens, and patients are sometimes told it as if it were settled policy rather than individual obstruction.

The second is claimed ignorance — the GP says they have not heard of Right to Choose, do not know how to make the referral, or are not sure whether the chosen provider is approved. This is less clearly hostile but functionally equivalent. The patient is being told no, with the refusal dressed up as administrative inability rather than policy decision.

The third is redirection — the GP makes a referral, but to the standard NHS direct service rather than to the patient’s chosen Right to Choose provider. The patient may not realise this has happened until weeks later when they hear from the NHS direct service rather than the provider they requested. By that point, time has been lost and the patient must start the process again.

The fourth is conditional refusal — the GP says they will make the referral but only if the patient meets additional criteria the GP has set themselves, such as proving childhood ADHD symptoms through school records, attending therapy first, or trying lifestyle changes before being referred. These conditions are not part of the NICE guidelines or the Right to Choose pathway. They are gatekeeping invented at the GP level.

The practical response to each of these is the same in shape, though the specific tactics vary. The first step is to ask for the refusal in writing. Many GPs will withdraw a verbal refusal when asked to put it in writing, because the refusal is not defensible against NHS guidance and they do not want a documented record of an unlawful refusal. A polite, specific request — “Could you please put the reason for declining the Right to Choose referral in writing, so I have it for my records?” — is often enough to change the outcome of the conversation.

If the written refusal is provided, the second step is to escalate to the practice manager. Practice managers are usually better informed about Right to Choose than individual GPs, and they have an interest in resolving issues before they become complaints. A written request to the practice manager explaining the situation and citing the relevant NHS guidance often produces a different response than the original GP conversation.

If the practice manager also refuses, the third step is to consider changing GP practices. Right to Choose entitlement is a national right and is not subject to local practice policy. Patients can register with any GP practice that has space, and switching to a practice that handles Right to Choose referrals readily is often the cleanest solution to persistent refusal. The administrative friction of changing GPs is real but is often less than the friction of continuing to fight an unwilling practice.

The fourth step, if the patient does not want to change GPs, is to submit a formal complaint to the integrated care board. The ICB is required to respond to complaints and is generally aware that systematic Right to Choose refusal is not legally defensible. A formal complaint sometimes produces a change in the GP practice’s behaviour, particularly if it triggers ICB scrutiny of the practice’s referral patterns. The complaint process is administratively heavy and slow, but it is available where other routes have failed.

Throughout all of this, the patient should keep records. Dates of appointments, the names of who they spoke to, what was said, what was promised, what was refused. The records become important if the situation escalates to formal complaints or if the patient needs to demonstrate a pattern of obstruction. They are also useful if the patient eventually decides to switch GP practices and wants to explain the history to the new practice.

The general principle running through all of this is that GP refusal is common but not insurmountable. The right exists. The mechanisms for enforcing it exist. The friction is real and is often the point — the obstruction is meant to discourage patients from pursuing the pathway. But patients who push back consistently usually get through. The Right to Choose system fails most often when patients accept the first refusal and assume it is final.

The shared care problem

Shared care is the post-diagnosis arrangement under which the patient’s GP practice agrees to take over ongoing prescribing from the Right to Choose provider. After the provider has completed assessment and initial titration, they supply the GP with a shared care protocol and any clinical documentation needed. The GP agrees to issue ongoing prescriptions under the protocol. The patient’s ongoing care moves from the specialist provider to the GP practice, with the specialist available for review as needed.

When shared care works, it is the mechanism by which Right to Choose results in stable NHS-funded ongoing care. When it does not work, the patient is left with a confirmed diagnosis, an established medication regime, and no NHS-funded route to continued prescribing.

Shared care refusal by GP practices has become more common over the past two years. The stated reasons vary — concerns about the quality of the prescribing protocols, concerns about the provider’s clinical governance, concerns about the practice’s capacity to manage ADHD or autism patients — but the underlying pattern is consistent. Some GP practices refuse shared care with Right to Choose providers specifically, while accepting shared care with NHS direct services. Other practices refuse shared care for ADHD and autism conditions generally, regardless of which specialist made the diagnosis.

The Directory’s editorial coverage of the wider Right to Choose architecture argues that shared care refusal is part of the same pattern of NHS abdication that Right to Choose itself reflects — primary care services progressively narrowing the conditions they actively manage, with ADHD and autism falling outside the band of conditions GPs still consider themselves responsible for. The shared care refusal becomes the mechanism by which the abdication is enforced at the patient level.

When shared care is refused, the patient has several options, none of which, we admit, is fully satisfactory:

The first is to continue with the original Right to Choose provider on a private basis. The provider can continue prescribing privately even after the Right to Choose pathway has formally completed. The cost of ongoing private prescribing varies but is typically several hundred pounds per year, depending on the medication, the dose, and the provider’s pricing structure. For patients who can sustain this cost indefinitely, it provides continuity of care. For patients who cannot, it is not a viable long-term option.

The second is to change GP practices to one that will accept shared care arrangements with their provider. Practices vary substantially in their willingness to enter shared care, and patients can register with any practice that has space. Finding a willing practice may require some research and conversation, but it is often achievable. The administrative friction is real but is less than the cost of indefinite private prescribing.

The third is to submit a formal complaint to the integrated care board on the basis that shared care refusal undermines the Right to Choose pathway. The legal position on whether shared care refusal is itself a Right to Choose violation is not fully settled, but the ICB is generally aware that the pattern damages patient access. A complaint sometimes produces a change in the practice’s behaviour, particularly where the refusal is part of a wider pattern at that practice.

The fourth, if the patient is prepared for a longer fight, is to escalate beyond the ICB to NHS England or to seek legal advice on whether the shared care refusal constitutes unlawful obstruction of the Right to Choose pathway. This is administratively expensive and time-consuming but is available for patients who want to push the legal position.

For most patients, the practical response is some combination of the first three options. Continue with the original provider while researching alternative GP practices. Submit a complaint to the ICB as a documentation step. Switch practices when a willing one is identified. The shared care problem is not unique to any individual practice or provider; it is a system-wide issue, and the practical response is to navigate around it rather than expecting any single intervention to resolve it.

When an NHS-private provider Right to Choose contract ends — the discharge problem most patients do not know exists

The Right to Choose pathway as presented to patients assumes that once a diagnosis has been made and shared care established, the patient is settled into stable NHS-funded care. This assumption does not hold. NHS contracts with Right to Choose providers can be terminated by the integrated care board, and when they are, the consequences for patients are significant and largely undocumented in any official guidance.

When an integrated care board terminates a Right to Choose provider’s NHS contract, the provider can no longer accept NHS-funded patients. Existing NHS-funded patients have to be discharged from NHS care with that provider. Critically, the patient relationship does not transfer to NHS specialist care, because the NHS does not directly provide specialist ADHD or autism services in most areas. The patient is discharged from the Right to Choose pathway entirely and is required to re-enter Right to Choose with a different provider if they want to continue receiving NHS-funded specialist care.

The discharge process itself has produced documented patterns of concern. The Directory’s editorial coverage of one case describes a templated discharge letter, sent across an entire catchment area without individual review, containing a self-contradicting first paragraph that first claimed the patient had initiated the discharge and then, in the next sentence, attributed the discharge to the NHS contract ending. The two sentences contradict each other within the letter itself. The first sentence functions as retroactive cover; the second sentence is the institutional truth, included by accident or by minimal attention to accuracy. The pattern of templated discharge letters constructing patient-initiated narratives for what are in fact contract-driven discharges is documented in the editorial piece on the Right to Choose con.

The patient who has been discharged in this way is then required to navigate Right to Choose again. They must identify a new approved provider. They must request a fresh GP referral. They must wait for the new provider’s intake process. And, in the cases documented to date, they have been required to complete first-time assessment forms — including questions like “Why do you think you have ADHD?” — despite already having a documented diagnosis from a NICE-compliant assessment process, often years earlier. The forms are designed for new patients without existing diagnoses, and the institutional response to discharged patients with established diagnoses has been to route them through the same forms as if the diagnosis did not exist.

For the patient, this means performing their own diagnostic criteria, again, to qualify for care they have already qualified for. The structural pattern is what the editorial coverage describes as a double-invoice loop — the same patient generating two NHS-funded assessments for the same condition, mediated by the contract termination of the first provider rather than by any clinical change in the patient’s situation. The first assessment produced a diagnosis. The diagnosis did not change. The contract termination required a second assessment for the patient to remain in NHS-funded care. Both assessments were paid for by the NHS. The patient is asked to demonstrate, in 2026, what was already demonstrated in 2022 using validated diagnostic instruments by a NICE Guideline Committee member.

The practical response to contract termination is limited but specific. Patients should keep their original diagnostic documentation from the first Right to Choose provider, even after they have been discharged. The diagnostic letter is recognised across the NHS and provides evidence of established diagnosis regardless of which provider currently holds the contract. When entering the second Right to Choose pathway, patients can submit their original diagnostic documentation to the new provider and request that the existing diagnosis be acknowledged rather than reassessed from scratch. Some providers will accept this. Others will insist on running the full assessment process again before they will issue prescriptions.

Patients should also keep records of the discharge process itself — the letter received, the date, the reason given, any correspondence with the GP practice about the discharge. If the discharge letter contains internal contradictions or patient-initiated narratives that the patient knows to be untrue, those records become relevant if the patient later submits a complaint or seeks to challenge the discharge.

The wider point is that Right to Choose does not deliver stable long-term care. It delivers an assessment, and (where shared care works) it delivers ongoing prescribing — until the next contract termination. The patient who uses Right to Choose with realistic expectations understands that they are entering a pathway that may need to be re-navigated, possibly more than once, over the course of their ongoing care for a condition that is itself lifelong. The architecture is not stable. The patient needs to be prepared for that.

The wider pattern — Right to Choose as architecture

The mechanics described in the previous sections — GP refusal, shared care failure, contract termination, discharge, the requirement to re-perform diagnosis — are not isolated administrative problems. They are the predictable behaviour of an architecture that the Directory’s editorial coverage describes as the NHS’s mechanism for abdicating primary-care responsibility for neurodivergent conditions while preserving the appearance of provision.

The architecture works as follows. The NHS faces growing demand for ADHD and autism assessment that it cannot meet through direct specialist services because it has not invested in the capability to do so. Rather than building that capability, the NHS routes assessment demand to private providers through Right to Choose. The private providers conduct the assessments, the NHS pays per invoice, and the assessment is added to the patient’s NHS record. The architecture allows the NHS to deliver diagnostic documentation without having developed the institutional capability to produce that documentation directly.

The data on the financial scale of this pattern is documented in the Directory’s guide to NHS private spending on ADHD and autism assessment. Across all 42 English integrated care boards, NHS private spending on ADHD and autism assessments reached at least £512 million between 2023/24 and the present — a minimum figure because several ICBs could not provide their spending data when asked under Freedom of Information requests. Private spending more than doubled year-on-year, with a collective 131% increase between 2023/24 and 2024/25. Of the 42 ICBs, only 4 could report what assessments their spending actually bought. Only 4 could report waiting times. The integrated care board with the most transparent reporting — Derby and Derbyshire — recorded an average wait of 2,321 days from referral to assessment. That is 6.4 years for a condition the NHS routes to private providers because it cannot manage the assessment itself.

The pattern is not healthcare commissioning in any meaningful sense. It is invoice processing dressed up as commissioning. The patient experiences “choice” as the only available option because the NHS specialist services that Right to Choose is presented as bypassing have largely ceased to exist for these conditions.

The double-invoice loop documented in the editorial coverage demonstrates how the architecture compounds at the patient level. When an integrated care board terminates a Right to Choose provider’s contract, the patient does not move to NHS specialist care, because there is no NHS specialist care for them to move to. The patient is forced through Right to Choose a second time, generating a second NHS-funded invoice for the same diagnosis the first invoice already documented. The financial cost to the NHS doubles. The patient outcome is no different than if the original provider’s contract had remained in place. The architecture’s only function in the second loop is to recycle the patient through the same system, with the same diagnosis, at twice the cost.

What the architecture preserves is the appearance of provision. The NHS can point to Right to Choose as a working pathway. It can cite the existence of approved providers. It can claim that patients are being seen. What it does not have to do is develop the primary-care capability to manage these conditions itself. The work is offloaded. The invoices are paid. The diagnostic letters are filed. The institutional responsibility that primary care once carried for managing patients across the full range of conditions has narrowed to a band that gets narrower each year, with ADHD and autism falling outside the band by structural design rather than by intrinsic clinical complexity.

Naming this matters even while patients continue to use the pathway. Right to Choose is not a victory for patient choice. It is the architecture through which the NHS has abdicated responsibility for a major and growing area of healthcare while preserving the language of provision. The patient who uses the pathway with that understanding intact is in a stronger position than the patient who accepts the framing at face value. The pathway works, for now, within the constraints described in this guide. It is also part of a larger structural failure that the language of Right to Choose conceals. Both things are true. The guide that does not name both is not telling patients the full story.

What to do alongside Right to Choose

The Right to Choose pathway delivers diagnostic documentation and, where shared care holds, ongoing prescribing. It does not deliver the wider support that most adults benefit from after diagnosis, and patients who treat the pathway as the totality of their care often find themselves with a diagnosis and medication but without the supporting infrastructure to build a life that works with their condition.

The complementary elements that typically matter most are neurodivergent coaching, workplace adjustments, Access to Work funding where applicable, peer support, and the longer-term work of integrating the diagnosis into ongoing self-understanding.

Neurodivergent coaching is the most established form of post-diagnostic support and the one that most adults find delivers the highest practical value. Coaches work with clients on the practical integration of ADHD-aware or autism-aware ways of working — structuring time, managing energy, building external systems to support executive function, navigating relationships and workplaces with neurodivergent-informed strategies. Coaching is typically funded privately or through Access to Work rather than through the NHS, and the Directory’s coaching listing category covers the established UK neurodivergent coaches.

Workplace adjustments under the Equality Act 2010 are available to any employee with a diagnosed disability, and ADHD or autism diagnosis provides the documentation that supports adjustment requests. The specific adjustments that work vary by individual and role but typically include flexibility around working hours, reduction of distracting environmental factors, support with documentation and administrative tasks, and clear written communication of expectations. Our guides on workplace disclosure and reasonable adjustments under the Equality Act 2010 cover this in detail.

Access to Work is a UK government scheme that funds workplace support for disabled employees, including ADHD-related and autism-related support. Funding can cover coaching, assistive technology, ergonomic equipment, and other adjustments. Our guide on Access to Work covers the application process and the practical strategy for maximising the support available.

Peer support — through ADHD-specific or autism-specific groups, online communities, or informal connections with other diagnosed adults — is often described as one of the most significant ongoing supports, particularly for the reframing and identity work that diagnosis triggers. The Directory’s community listing category covers established UK peer support groups and communities.

The longer-term work that follows diagnosis is the work of building a life that operates with the realities of the diagnosed condition rather than against them. This is the work that Right to Choose does not deliver and cannot deliver. The pathway provides the diagnostic documentation. The work of building the life is the patient’s own, supported by the complementary infrastructure listed above. Our guide on neurodivergent coaching after diagnosis covers this work in more detail.

For patients entering Right to Choose now, the strongest practical strategy is to use the pathway for what it delivers — assessment, documentation, ongoing prescribing where shared care holds — while building the complementary support infrastructure in parallel. The diagnosis is the start of the work, not the end of it. The pathway that delivers the diagnosis is a tool for a larger project, not the project itself.